Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Published in: International Urology and Nephrology 6/2016

01-06-2016 | Urology - Review

Updates of underactive bladder: a review of the recent literature

Authors: Xing Li, Limin Liao

Published in: International Urology and Nephrology | Issue 6/2016

Login to get access

Abstract

Underactive bladder (UAB) is a major component of lower urinary tract symptoms. The physiopathology mechanisms underlying UAB include detrusor underactivity, acontractile detrusor, and reduced or absent bladder sensation. UAB can influence lower and upper urinary tract function and lead to serious consequences; however, the symptom syndrome is poorly understood and incompletely researched at present. Moreover, there is no agreement among authorities regarding the terminology, definition, epidemiology, classification, risk factors, animal model, pathogenesis, diagnosis, and treatment of UAB. In this review, we discuss the current terminology, epidemiology, physiopathology, evaluation, and management of UAB.
Literature
1.
Abrams P et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol 187(1):116–126CrossRefPubMed
2.
3.
Chapple C (2013) Overactive bladder and underactive bladder: a symptom syndrome or urodynamic diagnosis? Neurourol Urodyn 32(4):305–307CrossRefPubMed
4.
Valente S et al (2014) Epidemiology and demographics of the underactive bladder:a cross-sectional survey. Int Urol Nephrol 46(Suppl 1):S7–S10CrossRefPubMed
5.
Taylor JA 3rd, Kuchel GA (2006) Detrusor underactivity: clinical features and pathogenesis of an underdiagnosed geriatric condition. J Am Geriatr Soc 54(12):1920–1932CrossRefPubMed
6.
7.
Smith PP (2010) Aging and the underactive detrusor: a failure of activity or activation? Neurourol Urodyn 29(3):408–412PubMed
8.
Osman NI et al (2014) Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol 65(2):389–398CrossRefPubMed
9.
10.
van Koeveringe GA et al (2011) Detrusor underactivity: a plea for new approaches to a common bladder dysfunction. Neurourol Urodyn 30(5):723–728CrossRefPubMed
11.
12.
Eqqilmez T, Resit Goren M (2014) Catheterized uroflowmetry as a noninvasive test for detrusor acontractility. Urol Int 92(3):316–322CrossRef
13.
Stav K et al (2013) Comparison of lower urinary tract symptoms between women with detrusor overactivity and impaired contractility, and detrusor overactivity and preserved contractility. J Urol 189(6):2175–2178CrossRefPubMed
14.
Griffiths DJ et al (2002) Urge incontinence and impaired detrusor contractility in the elderly. Neurourol Urodyn 21(2):126–131CrossRefPubMed
15.
Yamamoto T et al (2006) Neurological diseases that cause detrusor hyperactivity with Impaired contractile function. Neurourol Urodyn 25(4):356–360CrossRefPubMed
16.
17.
Chancellor MB, Kaufman J (2008) Case for pharmacotherapy development for underactive bladder. Urology 72(5):966–967CrossRefPubMed
18.
19.
Cucchi A et al (2007) Urodynamic findings suggesting two-stage development of idiopathic detrusor underactivity in adult men. Urology 70(1):75–79CrossRefPubMed
20.
Smith PP, Chalmers DJ, Feinn RS (2015) Does defective volume sensation contribute to detrusor underactivity? Neurourol Urodyn 34(8):752–756CrossRefPubMed
21.
Chancellor MB, Diokno A (2014) CURE-UAB: shedding light on the underactive bladder syndrome. Int Urol Nephrol 46(Suppl 1):S1CrossRefPubMed
22.
Suskind AM, Smith PP (2009) A new look at detrusor underactivity: impaired contractility versus afferent dysfunction. Curr Urol Rep 10(5):347–351CrossRefPubMed
23.
Jeong SJ et al (2012) Prevalence and clinical features of detrusor underactivity among elderly with lower urinary tract symptoms: a comparison between men and women. Korean J Urol 53(5):342–348CrossRefPubMedPubMedCentral
24.
Abarbanel J, Marcus EL (2007) Impaired detrusor contractility in community dwelling elderly presenting with lower urinary tract symptoms. Urology 69(3):436–440CrossRefPubMed
25.
Diokno AC et al (1986) Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J Urol 136(5):1022–1025PubMed
26.
Belenky A et al (2003) Detrusor resistive index evaluated by Doppler ultrasonography as a potential indicator of bladder outlet obstruction. Urology 62(4):647–650CrossRefPubMed
27.
Thomas AW et al (2005) The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of untreated detrusor underactivity. BJU Int 96(9):1295–1300CrossRefPubMed
28.
Lee JG, Shim KS, Koh SK (1999) Incidence of detrusor underactivity in men with prostatism older than 50 years. Korean J Urol 40(3):347–352
29.
Smith PP, Hurtado EA, Appell RA (2009) Post hoc interpretation of urodynamic evaluation is qualitatively different than interpretation at the time of urodynamic study. Neurourol Urodyn 28(8):998–1002CrossRefPubMed
30.
Cucchi A, Quaglini S, Rovereto B (2008) Development of idiopathic detrusor underactivity in women: from isolated decrease in contraction velocity to obvious impairment of voiding function. Urology 71(5):844–848CrossRefPubMed
31.
Kuo HC (2007) Recovery of detrusor function after urethral botulinum A toxin injection in patients with idiopathic low detrusor contractility and voiding dysfunction. Urology 69(1):57–61CrossRefPubMed
32.
Andersson KE, Arner A (2004) Urinary bladder contraction and relaxation:physiology and pathophysiology. Physiol Rev 84(3):935–986CrossRefPubMed
33.
Oshiro T, Miyazato M, Saito S (2014) Relationship between connexin43-derived gap junction proteins in the bladder and age-related detrusor underactivity in rats. Life Sci 116(1):37–42CrossRefPubMed
34.
35.
36.
37.
Meng NH et al (2010) Incomplete bladder emptying in patients with stroke: Is detrusor external sphincter dyssynergia a potential cause? Arch Phys Med Rehabil 91(7):1105–1109CrossRefPubMed
38.
Campos-Sousa RN et al (2003) Urinary symptoms in Parkinson’s disease: prevalence and associated factors. Arq Neuropsiquiatr 61(2B):359–363CrossRefPubMed
39.
Mesrobian HG (2014) Complete primary repair of bladder exstrophy is associated with detrusor underactivity type of neurogenic bladder. Urology 83(5):1139–1144CrossRefPubMed
40.
Giannantoni A et al (2004) Assessment of bladder and urethral sphincter function before and after radical retropubic prostatectomy. J Urol 171(4):1563–1566CrossRefPubMed
41.
Kielb SJ, Clemens JQ (2005) Comprehensive urodynamics evaluation of 146 men with incontinence after radical prostatectomy. Urology 66(2):392–396CrossRefPubMed
42.
Kitta T et al (2015) Postoperative detrusor contractility temporarily decreases in patients undergoing pelvic organ prolapse surgery. Int J Urol 22(2):201–205CrossRefPubMed
43.
Araki I et al (2009) Incontinence and detrusor dysfunction associated with pelvic organ prolapse: clinical value of preoperative urodynamic evaluation. Int Urogynecol J Pelvic Floor Dysfunct 20(11):1301–1306CrossRefPubMed
44.
Hakvoort RA et al (2009) Predicting short-term urinary retention after vaginal prolapse surgery. Neurourol Urodyn 28(3):225–228CrossRefPubMed
45.
46.
Bozikas V, Petrikis P, Karavatos A (2001) Urinary retention caused after fluoxetine-risperidone combination. J Psychopharmacol 15(2):142–143CrossRefPubMed
47.
Delgado JH et al (2004) Acute, transient urinary retention from combined ecstasy and methamphetamine use. J Emerg Med 26(2):173–175CrossRefPubMed
48.
Changolkar AK et al (2005) Diabetes induced decrease in detrusor smooth muscle force is associated with oxidative stress and overactivity of aldose reductase. J Urol 173(1):309–313CrossRefPubMed
49.
Chu FM, Dmochowski R (2006) Pathophysiology of overactive bladder. Am J Med 119(3 Suppl. 1):S3–S8CrossRefPubMed
50.
Sekido N et al (2012) A novel animal model of underactive bladder: analysis of lower urinary tract function in a rat lumbar canal stenosis model. Neurourol Urodyn 31(7):1190–1196CrossRefPubMed
51.
Jiang HH et al (2013) Bladder dysfunction changes from underactive to overactive after experimental traumatic brain injury. Exp Neurol 240:57–63CrossRefPubMed
52.
Saito M, Miyagawa I (2001) Bladder dysfunction after acute urinary retention in rats. J Urol 165(5):1745–1747CrossRefPubMed
53.
Kim DK et al (2009) Cystometric changes in pressure-guided acute distension rat model of the underactive bladder. Tzu Chi Med J 21(2):136–139
54.
Somogyi GT et al (2002) Effect of cryoinjury on the contractile parameters of bladder strips: a model of impaired detrusor contractility. Brain Res Bull 59(1):23–28CrossRefPubMed
55.
Nomiya M et al (2014) Progressive vascular damage may lead to bladder underactivity in rats. J Urol 191(5):1462–1469CrossRefPubMed
56.
Munoz A et al (2011) Overactive and underactive bladder dysfunction is reflected by alterations in urothelial ATP and NO release. Neurochem Int 58(3):295–300CrossRefPubMed
57.
Young JS et al (2013) The passive and active contractile properties of the neurogenic, underactive bladder. BJU Int 111(2):355–361CrossRefPubMed
58.
Nirmal J et al (2014) Functional and molecular characterization of hyposensitive underactive bladder tissue and urine in streptozotocin-induced diabetic rat. PLoS ONE 9(7):e102644CrossRefPubMedPubMedCentral
59.
Lai HH et al (2007) Using caveolin-1 knockout mouse to study impaired detrusor contractility and disrupted muscarinic activity in the aging bladder. Urology 69(2):407–411CrossRefPubMed
60.
van Koeveringe GA et al (2014) Detrusor underactivity: pathophysiological considerations, models and proposals for future research. ICI-RS 2013. Neurourol Urodyn 33(5):591–596CrossRefPubMedPubMedCentral
61.
Ukimura O et al (2003) Ultrasonic measurement of bladder weight as a novel urodynamic modality. Adv Exp Med Biol 539(Pt A):311–315
62.
Chancellor MB (2014) The overactive bladder progression to underactive bladder hypothesis. Int Urol Nephrol 46(Suppl 1):S23–S27CrossRefPubMed
63.
Cucchi A, Quaglini S, Rovereto B (2010) Different evolution of voiding function in underactive bladders with and without detrusor overactivity. J Urol 183(1):229–233CrossRefPubMed
64.
Casanova N, McGuire E, Fenner DE (2006) Botulinum toxin: a potential alternative to current treatment of neurogenic and idiopathic urinary incontinence due to detrusor overactivity. Int J Gynaecol Obstet 95(3):305–311CrossRefPubMed
65.
Bromage SJ et al (2010) Urodynamics in the octogenarian female: Is it worthwhile? Int Urogynecol J 21(9):1117–1121CrossRefPubMed
66.
Schaefer W (1990) Basic principles and clinical application of advanced analysis of bladder voiding function. Urol Clin N Am 17(3):553–566
67.
Liao L, Schaefer W (2009) Within-session reproducibility and variability of urethral resistance and detrusor contractility in pressure-flow studies in men with lower urinary tract symptoms. Curr Urol 3(1):19–28
68.
Griffiths DJ (1991) Assessment of detrusor contraction strength or contractility. Neurourol Urodyn 10(1):1–18CrossRef
69.
Abrams P (1999) Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int 84(1):14–15CrossRefPubMed
70.
Sullivan MP, Yalla SV (1996) Detrusor contractility and compliance characteristics in adult male patients with obstructive and nonobstructive voiding dysfunction. J Urol 155(6):1995–2000CrossRefPubMed
71.
Schäfer W (1995) Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple. World J Urol 13(1):47–58CrossRefPubMed
72.
Cucchi A, Quaglini S, Rovereto B (2009) Proposal for a urodynamic redefinition of detrusor underactivity. J Urol 181(1):225–229CrossRefPubMed
73.
Andersson KE (2010) Detrusor underactivity/underactive bladder: new research initiatives needed. J Urol 184(5):1829–1830CrossRefPubMed
74.
Jhang JF, Jiang YH, Kuo HC (2014) Transurethral Incision of the bladder neck improves voiding efficiency in female patients with detrusor underactivity. Int Urogynecol J 25(5):671–676CrossRefPubMed
75.
Barendrecht MM et al (2007) Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU Int 99(4):749–752CrossRefPubMed
76.
Barrett DM (1981) The effect of oral bethanechol chloride on voiding in female patients with excessive residual urine: a randomized double-blind study. J Urol 126(5):640–642PubMed
77.
Bougas DA et al (2004) Clinical efficacy of distigmine bromide in the treatment of patients with underactive detrusor. Int Urol Nephrol 36(4):507–512CrossRefPubMed
78.
Dasgupta R (2004) Prostaglandin E2 and bethanechol in combination for treating detrusor underactivity. BJU Int 94(1):191–192CrossRefPubMed
79.
80.
Rahnama’i MS et al (2012) The role of prostanoids in urinary bladder physiology. Nat Rev Urol 9(5):283–290CrossRefPubMed
81.
Kim JC et al (2005) Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom. Int Urol 12(10):875–880CrossRef
82.
Sakakibara R et al (2000) Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte. J Auton Nerv Syst 79(2–3):191–195CrossRefPubMed
83.
Chang SJ, Chiang IN, Yu HJ (2008) The effectiveness of tamsulosin in treating women with voiding difficulty. Int J Urol 15(11):981–985CrossRefPubMed
84.
Yamanishi T et al (2004) Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int J Urol 11(2):88–96CrossRefPubMed
85.
Yoshii K et al (2011) Mechanism for distribution of acotiamide, a novel gastroprokinetic agent for treatment of functional dyspepsia, in rat stomach. J Pharm Sci 100(11):4965–4973CrossRefPubMed
86.
Sugimoto K et al (2015) A pilot study of acotiamide hydrochloride hydrate in patients with detrusor underactivity. Res Rep Urol 7:81–83PubMedPubMedCentral
87.
Phelan MW et al (2001) Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 165(4):1107–1110CrossRefPubMed
88.
Mokhless I et al (2006) Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder. J Urol 176(4 Pt 2):1767–1770CrossRefPubMed
89.
Liao YM, Kuo HC (2007) Causes of failed urethral botulinum toxin A treatment for emptying failure. Urology 70(4):763–766CrossRefPubMed
90.
Thorner DA et al (2014) Outcomes of reduction cystoplasty in men with impaired detrusor contractility. Urology 83(4):882–886CrossRefPubMed
91.
Gakis G et al (2011) Functional detrusor myoplasty for bladder acontractility: long-term results. J Urol 185(2):593–599CrossRefPubMed
92.
Moreno-Palacios J et al (2012) Outcomes and complications of sphincterotomy with bladder neck incision in neurologically healthy male patients with voiding dysfunction. Arch Esp Urol 65(2):244–250PubMed
93.
Mhiri MN, Bahloul A, Chabchoub K (2007) Mitrofanoff appendicovesicostomy in children: indication and results. Prog Urol 17(2):245–249CrossRefPubMed
94.
Kari J et al (2013) Is Mitrofanoff a more socially accepted clean intermittent catheterization (CIC) route for children and their families? Eur J Pediatr Surg 23(5):405–410PubMed
95.
Lombardi G et al (2014) Sacral neuromodulation for neurogenic non-obstructive urinary retention in incomplete spinal cord patients: a ten-year follow-up single-centre experience. Spinal Cord 52(3):241–245CrossRefPubMed
96.
Swinn MJ et al (2000) Sacral neuromodulation for women with Fowler’s syndrome. Eur Urol 38(4):439–443CrossRefPubMed
97.
Kavia R et al (2010) A functional magnetic resonance imaging study of the effect of sacral neuromodulation on brain responses in women with Fowler’s syndrome. BJU Int 105(3):366–372CrossRefPubMed
98.
Stöhrer M et al (2009) EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol 56(1):81–88CrossRefPubMed
Metadata
Title
Updates of underactive bladder: a review of the recent literature
Authors
Xing Li
Limin Liao
Publication date
01-06-2016
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 6/2016
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1251-x

Other articles of this Issue 6/2016

International Urology and Nephrology 6/2016 Go to the issue

Urology – Letter to the Editor

The effects of oxidative stress following ischemia–reperfusion injury

Nephrology – Original Paper

Peritoneal dialysis can be an option for unplanned chronic dialysis: initial results from a developing country

Urology - Original Paper

Water consumption and urinary tract infections: an in vitro study

Urology - Original Paper

Tumor size is associated with compensatory hypertrophy in the contralateral kidney after radical nephrectomy in patients with renal cell carcinoma

Urology - Review

Urological complications of uterine leiomyoma: a review of literature

Nephrology - Original Paper

The relation of postprandial plasma glucose and serum endostatin to the urinary albumin excretion of residents with prediabetes: results from the Kyushu and Okinawa Population Study (KOPS)

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits